Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
L2P Research Labs is a minority-owned, GLP-compliant contract research organization specializing in preclinical R&D support for pharmaceutical development. The company provides proprietary orthotopic and metastatic tumor models, efficacy studies, immuno-oncology models, IND-enabling GLP/non-GLP studies, animal imaging technologies, and bioanalytical services. Their work has contributed to published data in high-impact journals such as Cell Reports and Science Advances. They have supported the development of small molecules like Alphataxin for renal carcinoma by providing advanced tumor modeling capabilities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on L2P Research Labs.